id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0605-0054,FDA,FDA-2011-D-0605,Scientific Considerations in Demonstrating Biosimilarity to a Reference Product; Guidance for Industry; Availability,Notice,Notice of Availability,2015-04-30T04:00:00Z,2015,4,2015-04-30T04:00:00Z,,2025-11-20T19:18:14Z,2015-10062,0,0,0900006481ac4844
FDA-2011-D-0605-0055,FDA,FDA-2011-D-0605,Scientific Considerations in Demonstrating Biosimilarity to a Reference Product; Guidance for Industry,Other,Guidance,2015-04-28T04:00:00Z,2015,4,2015-04-28T04:00:00Z,,2025-11-05T10:00:14Z,,1,0,0900006481ac5991